Oracle and AstraZeneca are expanding their partnership to bring AI tools into healthcare, targeting faster clinical trials and improved patient care. The collaboration combines AstraZeneca's medical research with Oracle's cloud and data capabilities, focusing on oncology, cardiovascular disease, respiratory conditions, and rare diseases. The first global program is set to launch in Abu Dhabi in partnership with M42, with AstraZeneca CEO Pascal Soriot announcing the initiative at the Future Health Summit. The initial project will address hypertension care and research.
Meanwhile, AI demand continues to reshape expectations across the tech sector. Bernstein raised its price target for ServiceNow to $266, the highest on Wall Street, as roughly 50% of customers adopt AI-native products during renewals. TD Cowen also lifted its target to $165, pointing to upgrades, security demand, and U.S. federal interest. ServiceNow aims to surpass $30 billion in annual subscription revenue by 2030, with AI playing a central role.
Not all AI developments are landing smoothly. Digital Sun cancelled the public Steam playtest for its game ReVamp after concerns that Claude Opus 5.5 could reverse-engineer and republish the game. A smaller Discord playtest will proceed before October 29, with the public version now expected around January. In financial markets, rising borrowing costs are putting pressure on debt-heavy AI companies like Coreweave and Firmus, and South Korea's Kospi Index fell 3.5% on October 20 amid AI capex fears.
On the hardware and institutional side, DigiKey is now the exclusive distributor of the Coralboard edge AI development board, which uses Coral NPU technology from Google Research and Synaptics Astra processors. Jordan Kuwait Bank appointed Suhail Ahmad Mahmoud Salman as Chief Artificial Intelligence Officer to lead its AI initiatives. Comet Holding reported a jump in Q3 sales driven by AI and semiconductor demand, and SpaceX beat Q3 earnings estimates with its Super Intelligence segment bringing in over half of quarterly revenue.
Researchers also introduced the Concordance Plausibility Check, or CPC, a framework designed to evaluate the credibility of human digital twin predictions. The system combines real-world evidence, simulation, and clinical knowledge, reporting Pass, Fail, or Indeterminate results for treatment predictions that cannot be directly observed in patients.
Key Takeaways
- <ul><li>Oracle and AstraZeneca are launching their first global AI healthcare program in Abu Dhabi, focusing on speeding up clinical trials and improving patient care pathways.</li><li>AstraZeneca CEO Pascal Soriot announced the initiative at the Future Health Summit, with initial work covering hypertension, oncology, cardiovascular, respiratory, and rare diseases.</li><li>Bernstein raised its ServiceNow price target to $266, the highest on Wall Street, as about 50% of customers adopt AI products during renewals.</li><li>ServiceNow targets over $30 billion in annual subscription revenue by 2030, with AI expected to drive growth in the second half of the year.</li><li>Digital Sun cancelled its public ReVamp playtest due to concerns that Claude Opus 5.5 could reverse-engineer and republish the game.</li><li>The Concordance Plausibility Check framework evaluates AI digital twin predictions using real-world evidence, simulation, and clinical knowledge, returning Pass, Fail, or Indeterminate results.</li><li>Comet Holding reported a jump in Q3 sales driven by AI and semiconductor demand, while SpaceX beat Q3 estimates with its Super Intelligence segment generating over half of quarterly revenue.</li><li>DigiKey is the exclusive distributor of the Coralboard edge AI development board, built on Coral NPU technology from Google Research and Synaptics Astra processors.</li><li>Jordan Kuwait Bank appointed Suhail Ahmad Mahmoud Salman as Chief Artificial Intelligence Officer to lead the bank's AI initiatives and improve customer experience.</li><li>Rising borrowing costs are pressuring debt-heavy AI companies, and South Korea's Kospi Index fell 3.5% on October 20 amid concerns that AI infrastructure spending may outpace real AI revenue.</li></ul>
Oracle and AstraZeneca team up on AI healthcare tools
Oracle and AstraZeneca agreed to work together on AI and data tools for healthcare. The goal is to help doctors find eligible patients for clinical trials faster. It may also speed up research and bring insights into everyday care. Initial areas include oncology, cardiovascular disease, respiratory disease, and rare diseases. The collaboration will combine AstraZeneca's science with Oracle's cloud, AI, and health data capabilities.
AstraZeneca and Oracle to launch first global AI program in Abu Dhabi
AstraZeneca and Oracle plan to launch their first global AI program in Abu Dhabi. The program will focus on speeding up clinical trials and improving patient care pathways. It will be run in partnership with M42. AstraZeneca CEO Pascal Soriot announced the plan at the Future Health Summit in Abu Dhabi.
AstraZeneca and Oracle use AI to improve clinical research
AstraZeneca partnered with Oracle to use AI in clinical research. The first program under the deal will focus on hypertension care and research in Abu Dhabi. AstraZeneca, a U.K. drugmaker, wants to use Oracle's AI, cloud, and data tools. The collaboration aims to make clinical trials and research more efficient.
ServiceNow gets $266 price target as AI demand grows
Bernstein raised its price target for ServiceNow to $266, the highest on Wall Street. The upgrade came because more customers are adopting ServiceNow's AI-native products. The stock rose 1% in premarket trading. Analyst Peter Weed kept an Outperform rating and expects AI to help revenue growth in the second half of the year.
Analysts lift ServiceNow targets on strong AI adoption
Bernstein and TD Cowen raised their price targets for ServiceNow. Bernstein set its target at $266, noting about 50% of customers are adopting AI products during renewals. TD Cowen set its target at $165, pointing to upgrades, security, cross-selling, and U.S. federal demand. ServiceNow wants over $30 billion in annual subscription revenue by 2030, with AI playing a key role.
AI cloning forces Digital Sun to cancel ReVamp public playtest
Digital Sun cancelled the public Steam playtest for its game ReVamp due to concerns about AI cloning. The studio cited Claude Opus 5.5 being able to reverse-engineer and republish games. A smaller Discord playtest will start before October 29. The public playtest is now expected around January.
New framework checks credibility of AI digital twin predictions
Researchers proposed the Concordance Plausibility Check, or CPC, for human digital twins. CPC evaluates treatment predictions that cannot be directly observed in patients. It combines real-world evidence, simulation, and clinical knowledge. The system reports Pass, Fail, or Indeterminate results.
Comet Holding sees Q3 sales growth from AI and chip demand
Switzerland's Comet Holding reported a jump in Q3 sales driven by AI and semiconductor demand. The company's results reflected strong market interest in these technology areas. The report was generated using Reuters automated tools.
Jordan Kuwait Bank names new Chief Artificial Intelligence Officer
Jordan Kuwait Bank appointed Suhail Ahmad Mahmoud Salman as Chief Artificial Intelligence Officer. He will lead the bank's AI initiatives and drive innovation. The bank aims to improve customer experience and decision-making through AI. Salman brings experience in AI and data science from regional organizations.
SpaceX Q3 earnings beat estimates on AI growth
SpaceX reported Q3 earnings and revenue that beat estimates, driven by AI growth. The Super Intelligence segment brought in over half of quarterly revenue. Starlink and Starship also boosted profits. The company faces challenges in scaling computing infrastructure and maintaining AI adoption.
Synaptics Coralboard edge AI board now available from DigiKey
DigiKey is now the exclusive distributor of the Coralboard edge AI development board. The board uses Coral NPU technology from Google Research and Synaptics Astra processors. It is built for rapid prototyping and low-power AI applications. The board supports cameras, displays, audio, Ethernet-over-USB, Wi-Fi and Bluetooth. It is designed for developers building smart edge devices.
Wall Street AI trade faces pressure from rising debt costs
The global AI trade is under pressure as investors question how tech companies can fund AI infrastructure. Rising borrowing costs are creating doubt about debt-heavy companies like Coreweave and Firmus. Investors have chased AI-linked stocks for much of 2026. The concerns follow earlier selloffs in software and chipmaker stocks.
Kospi falls 3.5% amid AI spending fears
South Korea's Kospi Index dropped 3.5% on October 20, 2026 as AI capex concerns hit tech stocks. SK Hynix neared its lowest close since April. The MSCI Asia Pacific Index fell 1% while S&P 500 futures rose 0.2%. The selloff reflected worry that AI infrastructure spending may outpace real AI revenue.
Sources
- Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
- AstraZeneca, Oracle to launch their first global AI program in Abu Dhabi: CEO
- AstraZeneca Partners With Oracle to Use AI in Clinical Trials
- ServiceNow gets Street-high $266 price target as AI adoption boosts growth outlook
- Analysts raise ServiceNow price targets on strong AI product adoption and growth outlook.
- AI Cloning Threatens To End Public Playtests For Video Games
- Concordance Plausibility Check for Intervention-Conditioned Human Digital Twins
- Switzerland's Comet Holding Q3 sales jump on AI, semiconductor demand
- Jordan Kuwait Bank Appoints Suhail Ahmad Mahmoud Salman As Chief Artificial Intelligence Officer
- SpaceX shares rise as earnings, revenue beat estimates on AI
- Synaptics® Coralboard™ Edge AI Development Board, Powered by Coral NPU technology from Google Research, Now Available Exclusively from DigiKey
- Wall Street’s booming AI trade under pressure as investors question debt-fuelled neocloud like Coreweave and Firmus
- Kospi Sinks 3.5% as AI Capex Fears Hit Tech Stocks
Comments
Please log in to post a comment.